Global Flow Cytometry Market Forecast to 2023: Opportunities with Growing Market Penetration in Emerging Countries & Growth in Stem Cell Research

News provided by

Jan 29, 2019, 07:30 ET

DUBLIN, Jan. 29, 2019 /PRNewswire/ --

The "Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents & Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Labs, Pharma-Biotech), Application, Region - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The global flow cytometry market is projected to reach USD 5,400.6 million by 2023 from USD 3,655.5 million in 2018, at a CAGR of 8.1%.

Flow cytometry is a technology that measures and analyzes multiple characteristics of cells in a sample fluid suspension by a light beam which passes through it. Growth in the flow cytometry market is driven by continuous technological advancements in flow cytometers, the increasing adoption of flow cytometry techniques in research activities and clinical trials, growing focus on immunology and immuno-oncology research, the high incidence and prevalence of HIV/AIDS and cancer, and the increasing availability of novel application-specific flow cytometry products.

Furthermore, growing market penetration in emerging countries, growth in stem cell research, adoption of recombinant DNA technology for antibody production, and the evolution of tandem flow cytometry technologies are also expected to offer growth opportunities for players operating in the flow cytometry market during the forecast period.

However, the high cost of flow cytometry instruments, the dearth of skilled professionals and insufficient knowledge regarding the use of flow cytometers are restraining the growth of this market. In this report, the flow cytometry market is categorized on the basis of technology, product & service, application, end user, and region.

Key Topics Covered:

1 Introduction

1.1 Objectives of the Study
1.2 Market Definition
1.3 Study Scope
1.4 Currency Used for the Study
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.2 Market Estimation Methodology
2.3 Data Triangulation Methodology
2.4 Research Assumptions and Limitations

3 Executive Summary

4 Premium Insights
4.1 Flow Cytometry: Market Overview
4.2 Flow Cytometry Market, By Product & Service, 2018 vs 2023
4.3 Flow Cytometry Market, By Application, 2018 vs 2023 (USD Million)
4.4 Flow Cytometry Market, By End User, 2018 vs 2023
4.5 Geographical Snapshot of the Flow Cytometry Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Technological Advancements in Flow Cytometers
5.2.1.2 Increasing Adoption of Flow Cytometry Techniques in Research Activities and Clinical Trials
5.2.1.3 Growing Focus on Immunology and Immuno-Oncology Research
5.2.1.4 High Incidence and Prevalence of Hiv/Aids and Cancer
5.2.1.5 Increasing Availability of Novel Application-Specific Flow Cytometry Products
5.2.2 Restraints
5.2.2.1 High Cost of Flow Cytometry Instruments
5.2.2.2 Dearth of Skilled Professionals and Insufficient Knowledge Regarding the Use of Flow Cytometers
5.2.3 Opportunities
5.2.3.1 Growing Market Penetration in Emerging Countries
5.2.3.2 Growth in Stem Cell Research
5.2.3.3 Adoption of Recombinant Dna Technology for Antibody Production
5.2.3.4 Evolution of Tandem Flow Cytometry Technologies
5.2.4 Challenges
5.2.4.1 Inadequate Infrastructure for Research in Emerging Countries
5.2.4.2 Complexities Related to Reagent Development
5.2.4.3 Limited Purchasing Power of End Users in Emerging Countries
5.3 Regulatory Challenges
5.3.1 Challenging Fda Requirements
5.3.2 Stringent Analyte-Specific Reagent (ASR) Rule
5.3.3 Validation Challenges for Cell-Based Instruments
5.3.4 Absence of Established Laboratory-Developed Test (LDT) Guidelines on Cell-Based Fluorescence Assays
5.3.5 Changing Regulatory Environment
5.3.6 The Necessity of IVD-Ce Marking
5.4 Reimbursement Scenario

6 Flow Cytometry Market, By Technology
6.1 Introduction
6.2 Cell-Based Flow Cytometry
6.2.1 Cell-Based Flow Cytometry to Account for the Largest Share of the Market
6.3 Bead-Based Flow Cytometry
6.3.1 Procedural Advantages Offered By Bead-Based Flow Cytometry to Drive the Growth of This Segment

7 Flow Cytometry Market, By Product & Service
7.1 Introduction
7.2 Reagents and Consumables
7.2.1 Growing Market Availability of Application-Specific Reagents to Drive the Demand Growth
7.3 Flow Cytometry Instruments
7.3.1 Cell Analyzers
7.3.1.1 Cell Analyzers Market, By Price Range
7.3.1.1.1 High-Range Cell Analyzers
7.3.1.1.1.1 High-Range Cell Analyzers Account for the Largest Share of the Cell Analyzers Market
7.3.1.1.2 Mid-Range Cell Analyzers
7.3.1.1.2.1 Wide Availability of Compact and High-Performance Analyzers in This Price Range Support Market Growth
7.3.1.1.3 Low-Range Cell Analyzers
7.3.1.1.3.1 Low-Range Analyzers Find Significant Adoption Among Price-Sensitive End Users
7.3.2 Cell Sorters
7.3.2.1 Cell Sorters Market, By Price Range
7.3.2.1.1 High-Range Cell Sorters
7.3.2.1.1.1 High-Range Cell Sorters Dominate the Market
7.3.2.1.2 Mid-Range Cell Sorters
7.3.2.1.2.1 Product Launches and A Balance Between Efficiency and Costs Have Enabled the Growth of This Market Segment
7.3.2.1.3 Low-Range Cell Sorters
7.3.2.1.3.1 Increasing Commercialization of Affordable Products has Driven Adoption of Low-Range Cell Sorters
7.4 Services
7.4.1 Wide Availability of Flow Cytometry Services is the Primary Driver of Market Growth
7.5 Software
7.5.1 Continuous Upgrades in Flow Cytometry Software to Fuel Market Growth
7.6 Accessories
7.6.1 Advantages Offered By Accessories for Product Upgrade to Drive the Demand

8 Flow Cytometry Market, By Application
8.1 Introduction
8.2 Research Applications
8.2.1 Pharmaceuticals & Biotechnology
8.2.1.1 Drug Discovery
8.2.1.1.1 Wide Usage of Flow Cytometry in Drug Discovery is the Primary Driver of Market Growth
8.2.1.2 Stem Cell Research
8.2.1.2.1 Accuracy and Precision of Flow Cytometry Have Made It A Prominent Tool in Stem Cell Research
8.2.1.3 in Vitro Toxicity Testing
8.2.1.3.1 Need to Reduce Time and Cost of Drug Development Processes Will Be A Key Factor Driving Market Growth
8.2.2 Immunology
8.2.2.1 Flow Cytometry Plays A Vital Role in Immunology Studies
8.2.3 Cell Sorting
8.2.3.1 The Increase in Cell-Based Research Activity has Boosted Growth in This Application Segment
8.2.4 Apoptosis
8.2.4.1 Flow Cytometry Techniques are Used to Identify Changes Occurring During Apoptosis
8.2.5 Cell Cycle Analysis
8.2.5.1 Any Abnormality in Dna Content Can Be Detected Using Flow Cytometry
8.2.6 Cell Viability
8.2.6.1 Cell Viability is A Key Parameter Studied Using Flow Cytometry
8.2.7 Cell Counting
8.2.7.1 Flow Cytometry Allows for Easy Differentiation of Cells Via Scattering Or Staining
8.2.8 Other Research Applications
8.3 Clinical Applications
8.3.1 Cancer
8.3.1.1 Cancer Applications Include Determination of Tumor Malignancy and Chromosome Enumeration
8.3.2 Hematology
8.3.2.1 Flow Cytometry Can Help Identify A Wide Variety of Cell Surfaces and Cytoplasmic Antigens
8.3.3 Immunodeficiency Diseases
8.3.3.1 Flow Cytometry Allows for Simultaneous, Multi-Parameter Cell Analysis
8.3.4 Organ Transplantation
8.3.4.1 Use of Flow Cytometry to Reduce Organ Rejection Rates has Contributed to Market Growth
8.3.5 Other Clinical Applications
8.4 Industrial Applications
8.4.1 Wide Industrial Application Base of Flow Cytometry to Drive Market Growth

9 Flow Cytometry Market, By End User
9.1 Introduction
9.2 Academic and Research Institutes
9.2.1 Rise in Research Activity and Industry-Academia Collaboration to Drive Market Growth
9.3 Hospitals & Clinical Testing Laboratories
9.3.1 Rising Awareness and Disease Prevalence Have Sustained the Demand for Flow Cytometry
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Growing Drug Discovery Activity to Drive Market Growth

10 Flow Cytometry Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 High Adoption of Advanced Flow Cytometry Products Among End Users to Drive Market Growth in the Us
10.2.2 Canada
10.2.2.1 Availability of Public and Private Funding for Research Activities to Boost the Demand for Flow Cytometry Products in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Growing Outsourcing of Clinical Diagnostic Services to Be the Key Trend in the German Flow Cytometry Market
10.3.2 UK
10.3.2.1 UK to Witness Growing Acceptance of Flow Cytometry Products for Clinical Diagnostics
10.3.3 France
10.3.3.1 Training and Awareness Programs By Social Organizations and Key Players Expected to Fuel the Adoption of Flow Cytometry in France
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Strong Infrastructure and Favorable Market Outlook Have Sustained Japan's Dominance in the APAC Market
10.4.2 China
10.4.2.1 China Accounts for the Second-Largest Share in the APAC Market
10.4.3 India
10.4.3.1 High Incidence of Hiv/Aids and Cancer to Drive the Demand for Flow Cytometry Instruments in India
10.4.4 Rest of Asia Pacific
10.5 Rest of the World

11 Competitive Landscape
11.1 Overview
11.2 Global Market Share Analysis (2017)
11.3 Competitive Scenario
11.3.1 Key Product Launches and Approvals (2015-2018)
11.3.2 Key Agreements, Partnerships, and Collaborations (2015-2018)
11.3.3 Key Acquisitions (2015-2018)
11.3.4 Key Expansions (2015-2018)

12 Company Profiles
12.1 Agilent Technologies
12.2 Apogee Flow Systems
12.3 Beckman Coulter (A Subsidiary of Danaher)
12.4 Becton, Dickinson and Company
12.5 Biomrieux S.A.
12.6 Bio-Rad Laboratories
12.7 Cytonome St
12.8 Enzo Life Sciences (A Wholly Owned Subsidiary of Enzo Biochem, Inc.)
12.9 Luminex
12.10 Merck KGaA
12.11 Miltenyi Biotec
12.12 Sony Biotechnology (A Wholly Owned Subsidiary of Sony Corporation of America)
12.13 Stratedigm
12.14 Sysmex Partec (A Subsidiary of Sysmex Corporation)
12.15 Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/gcmhv6/global_flow?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets